Management options for localized prostate cancer have largely remained the same for the past 30 years. 90Yttrium (90Y) radioembolization is a novel radiotherapy approach that offers the potential to deliver high-dose radiation therapy with minimal non-target radiation. However, currently no accurate way exists to evaluate radiation effects noninvasively following embolization. In this study, we sought to apply diffusion and dynamic contrast-enhanced perfusion MRI to investigate assess the effects of treatment following 90Y prostate artery radioembolization in a dog prostate model.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords